University of North Carolina, Lineberger Comprehensive Cancer Center is a clinical research site located in Chapel Hill, North Carolina, United States.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
University of North Carolina, Lineberger Comprehensive Cancer Center has participated in 4 clinical trials.
Therapeutic areas: Renal Cell Carcinoma, Estrogen Receptor-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer.
Sponsors: AVEO Pharmaceuticals, Inc., Indiana University, Shattuck Labs, Inc..
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of North Carolina, Lineberger Comprehensive Cancer Center has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of North Carolina, Lineberger Comprehensive Cancer Center has 4 clinical trials on record. Their work covers Renal Cell Carcinoma, Estrogen Receptor-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer.
Yes — University of North Carolina, Lineberger Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.